Article info
Clinical science
Topical bromfenac reduces the frequency of intravitreal bevacizumab in patients with branch retinal vein occlusion
- Correspondence to Dr Masahiko Shimura, Department of Ophthalmology, Tokyo Medical University Hachioji Medical Center, 1163 Tate-machi, Hachioji, Tokyo 193-0998, Japan; masahiko{at}v101.vaio.ne.jp
Citation
Topical bromfenac reduces the frequency of intravitreal bevacizumab in patients with branch retinal vein occlusion
Publication history
- Received December 3, 2013
- Revised May 13, 2014
- Accepted August 9, 2014
- First published September 2, 2014.
Online issue publication
January 20, 2015
Article Versions
- Previous version (2 September 2014).
- You are viewing the most recent version of this article.
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions